Atlas Trials

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Clinical trial NCT05488873 · UNKNOWN

Trial details

NCT number
NCT05488873
Sponsor
WinSanTor, Inc
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-induced Peripheral Neuropathy
Start date
2022-11-22
Primary completion
2026-04-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.